Yap Kim Choy - 01 Sep 2025 SCHEDULE 13G/A Report for Cyclacel Pharmaceuticals, Inc. Common Stock, par value $0.001 per share (CYCC)

Filing Manager: Yap Kim Choy
Reporting Manager: Yap Kim Choy
Security: Cyclacel Pharmaceuticals, Inc. Common Stock, par value $0.001 per share
Symbol: CYCC
Shares outstanding: 4,200,385 shares
Disclosed Ownership: 872,000 shares
Ownership: 21%
Form type: SCHEDULE 13G/A
Filing time: 02 Sep 2025, 06:09:58 UTC
Date of event: 01 Sep 2025
Previous filing: 18 Aug 2025
Next filing: 31 Oct 2025
SEC: View on sec.gov

Key filing fact

Yap Kim Choy disclosed 21% ownership in Cyclacel Pharmaceuticals, Inc. Common Stock, par value $0.001 per share (CYCC) on 01 Sep 2025.

Key facts

Yap Kim Choy filed SCHEDULE 13G/A for Cyclacel Pharmaceuticals, Inc. Common Stock, par value $0.001 per share (CYCC).
Disclosed ownership: 21%.
Date of event: 01 Sep 2025.

This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
You can verify ownership claims directly against the original SEC filing.

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

Reporting persons

Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Yap Kim Choy	21%	872,000	872,000	0	/s/ Yap Kim Choy	Yap Kim Choy

CIK / CUSIP context first

Broader feeds